Home
Clinitech Laboratory Ltd Share Price History
Clinitech Laboratory Ltd
BSE : 28 May, 2025
40.85-2.2 (-5.0%)
Prev Close
43.0
Open Price
40.8
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1200
Today's High / Low
40.8 / 40.8
52 WK High / Low
120.8 / 38.2
Market Price of Clinitech Laboratory Ltd
1M
1Y
3Y
5Y
Monitoring Clinitech Laboratory Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2021 |
|---|---|
| Sales (Cr.) | 5 |
| Sales YoY Gr. | - |
| Adj EPS | 6.04 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 20.86 |
Key Financial Parameters
| Parameter | 2021 |
|---|---|
| Return on Capital Emp. % | 30.69 |
| Op. Profit Mgn % | 19.12 |
| Net Profit Mgn % | 8.79 |
| Debt to Equity % | 0.38 |
Latest Shareholding
Promoters Holdings Over Time
About Clinitech Laboratory Ltd
- Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
- The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai. Clinitech Laboratory are a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane, Raigad and Navi Mumbai.
- Their Promoters have 30+ years of experience in diagnostic business.
- Promoters inspirational leadership has led Clinitech to be recognised as one of the trusted pathology lab in the region.
- They conduct more than 3 Lakh tests per year in NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment.
Popular Search
FAQs for Clinitech Laboratory Ltd Share Price History
What are the key events that typically impact Clinitech Laboratory Ltd's share price history?
Key events that impact Clinitech Laboratory Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Clinitech Laboratory Ltd's share price history?
Stock splits reduce the nominal price of Clinitech Laboratory Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Clinitech Laboratory Ltd?
Dividends can influence Clinitech Laboratory Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Clinitech Laboratory Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Clinitech Laboratory Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Clinitech Laboratory Ltd’s share price history?
To understand Clinitech Laboratory Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
